Bio-ReCell is a cell therapy research and development company that has developed the first closed and automated system for target cell separation and isolation that yields pure and viable cells. The Bio-ReCell System uses a proprietary antibody-based technology that does not use magnetic particles and produces cell eluates with no contaminants such as residual antibodies, chemicals, and particles. Cell isolation is performed in sterile, biocompatible, and closed-loop cartridges that are cell-type specific in under 30 minutes. The technology is scalable from single patient use to large-scale GMP manufacturing processes. We have developed several cartridges, primarily targeting mesenchymal stem cells for autologous transplantation and T-cells for CAR-T therapies. We are seeking commercial and research partnerships in the field of cell and gene manufacturing and novel clinical application development with clinical trials.